Identification of differentially methylated sites within unmethylated DNA domains in normal and cancer cells

Analytical Biochemistry

Volumn 356, Issue 2, 2006, Pages 202-207

  Tryndyak, Volodymyr ^a   Kovalchuk, Olga ^b   Pogribny, Igor P ^a  

^a NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^b UNIVERSITY OF LETHBRIDGE   (Canada)

Author keywords

Cancer; Detection; DNA methylation; Hypermethylation

Indexed keywords

ALKYLATION; CELLS; DIAGNOSIS; DISEASES; DNA; DNA SEQUENCES; ERROR DETECTION; METHYLATION; TISSUE CULTURE; TUMORS;

BREAST CANCER CELLS; CANCER; CANCER PROGRESSION; DNA METHYLATION; DNA METHYLATION PATTERN; HYPERMETHYLATION; REGULATORY SEQUENCES; RESTRICTION ENDONUCLEASES;

POLYMERASE CHAIN REACTION;

BIOLOGICAL MARKER; DNA; ENDONUCLEASE;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER CYTODIAGNOSIS; CANCER SCREENING; CONTROLLED STUDY; CPG ISLAND; DISEASE MARKER; DNA DEGRADATION; DNA DETERMINATION; DNA FINGERPRINTING; DNA METHYLATION; DNA SEQUENCE; DNA STRAND; EXON; GENE AMPLIFICATION; GENOME ANALYSIS; HUMAN; HUMAN CELL; LIVER; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DOMAIN; TANDEM REPEAT;

EID: 33747884603     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2006.05.019     Document Type: Article

References (40)

1. Egger G., Liang G., Aparicio A., and Jones P.A. Epigenetics in human disease and prospects for epigenetic therapy. Nature 429 (2004) 457-463
2. Jones P.A., and Baylin S.B. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3 (2002) 415-428
3. Feinberg A.P., and Tycko B. The history of cancer epigenetics. Nat. Rev. Cancer 4 (2004) 143-145
4. Jones P.A., and Martienssen R.A. A blueprint for a Humane Epigenome Project: the AACR Human Epigenome Workshop. Cancer Res. 65 (2005) 11241-11246
5. Feinberg A.P., and Vogelstein B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301 (1983) 89-92
6. Flatau E., Bogenmann E., and Jones P.A. Variable 5-methylcytosine levels in human tumor cell lines and fresh pediatric tumor explants. Cancer Res. 43 (1983) 4901-4905
7. Gama-Sosa M.A., Slagel V.A., Trewyn R.W., Oxenhandler R., Kuo K.C., Gehrke C.W., and Ehrlich M. The 5-methylcytosine content of DNA from human tumors. Nucleic Acids Res. 11 (1983) 6883-6894
8. Verma M., and Srivastava S. Epigenetic in cancer: implications for early detection and prevention. Lancet Oncol. 3 (2002) 755-763
9. Counts J.L., and I Goodman J. Alterations in DNA methylation may play a variety of roles in carcinogenesis. Cell 83 (1995) 13-15
10. Laird P P.W. The power and the promise of DNA methylation markers. Nat. Rev. Cancer 3 (2003) 253-266
11. Kawai J., Hirotsune S., Hirose K., Fushiki S., Watanabe S., and Hayashizaki Y. Methylation profiles of genomic DNA of mouse developmental brain detected by restriction landmark genomic scanning (RLGS) method. Nucleic Acids Res. 21 (1993) 5604-5608
12. Gonzalgo M.L., Liang G., Spruck III C.H., Zingg J.-M., Rideout III W.M., and Jones P.A. Identification and characterization of differentially methylated regions of genomic DNA by methylation-sensitive arbitrarily primed PCR. Cancer Res. 57 (1997) 594-599
13. Toyota M., Ho C., Jair K K.-W., Li Q., Ohe-Toyota M., Baylin S.B., and Issa J.-P.J. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res. 59 (1999) 2307-2323
14. Frigola J., Ribas M., Risques R.-A., and Peinado M.A. Methylome profiling of cancer cells of inter-methylated sites (AIMS). Nucleic Acids Res. 30 (2002) e28
15. Sadicovic B., Haines T.R., Butcher D.T., and Rodenhiser D.I. Chemically induced DNA hypomethylation in breast carcinoma cells detected by the amplification of intermethylated sites. Breast Cancer Res. 6 (2004) R329-R337
16. Huang T.H.-M., Perry M.R., and Laux D.E. Methylation profiling of CpG islands in human breast cancer cells. Hum. Mol. Genet. 8 (1999) 459-470
17. Webber M., Davies J.J., Witting D., Oakeley E.J., Haase M., Lam W.L., and Schübeler D. Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat. Genet. 37 (2005) 853-862
18. Rollins R.A., Haghighi F., Edwards J.R., Das R., Zhang M.Q., Ju J., and Bestor T.H. Large-scale structure of genomic methylation patterns. Genome Res. 16 (2006) 157-163
19. INK4A gene in early preneoplastic liver and tumors induced by folate/methyl deficiency in rats. Cancer Lett. 187 (2002) 69-75
20. M Ausubel F., Brent R., Kingston R.E., Moore D.D., Seidman J.G., and Smith J.A. Preparation of genomic DNA from mammalian tissue, 2.2.1-2.2.3. Current Protocols in Molecular Biology (1989), Wiley Interscience, New York
21. Sutherland E., Coe L., and Raleigh E.A. McrBC: a multisubunit GTP-dependent restriction endonuclease. J. Mol. Biol. 225 (1992) 327-348
22. Raleigh E.A. Organization and function of the mcrBC genes of Esherichia coli K-12. Mol. Microbiol. 6 (1992) 1079-1086
23. Rabinowicz P.D., Palmer L.E., May B.P., Hemann M.T., Lowe S.W., McCombie R., and Martienssen R.A. Genes and transposons are differentially methylated in plants, but not in mammals. Genome Res. 13 (2003) 2658-2664
24. Martens J.H.A., O'Sullivan R.J., Braunschweig U., Opravil S., Radolf M., Steinlein P., and Jenuwein T. The profile of repeat-associated histone lysine methylation states in the mouse epigenome. EMBO J. 24 (2005) 800-812
25. Yoder J.A., Walsh C.P., and Bestor T.H. Cytosine methylation and the ecology of intragenomic parasites. Trends Genet. 13 (1997) 376-378
26. Fazzari M.J., and Greally J.M. Epigenomics: beyond CpG islands. Nat. Rev. Genet. 5 (2004) 446-455
27. International Human Genome Sequencing Consortium, Initial sequencing and analysis of the human genome, Nature 420 (2001) 860-921.
28. Rat Genome Sequencing Project Consortium, Genome sequence of the Brown Norway rat yields insights into mammalian evolution, Nature 428 (2004) 493-521.
29. Lippman Z., Gendrel A.V., Colot V., and Martienssen R. Profiling DNA methylation patterns using genomic tiling microarrays. Nat. Methods 2 (2005) 219-224
30. Ueno M., Toyota M., Akino K., Suzuki H., Kusano M., Satoh A., Mita H., Sasaki Y., Nojima M., Yanagihara K., Hinoda Y., Tokino T., and Imai K. Aberrant methylation and histone deacetylation associated with silencing of SLC5A8 in gastric cancer. Tumour Biol. 25 (2004) 134-140
31. Rush L.J., Raval A., Funchain P., Johnson A.J., Smith L., Lucas D.M., Bembea M., Liu T.-H., Heerema N.A., Rassenti L., Liyanarachchi S., Davuluri R., Byrd J.C., and Plass C. Epigenetic profiling in chronic lymphoblastic leukemia reveals novel methylation targets. Cancer Res. 64 (2004) 2424-2433
32. van Doorn R., Zoutman W.H., Dijkman R., de Menezes R.X., Commandeur S., Mulder A.A., van der Velden P.A., Vermeer M.H., Willenze R., Yan P.S., Huang T.H., and Tensen C.P. Epigenetic profiling of cutaneous T-cell lymphoma: promoter hypermethylation of multiple tumor suppressor genes including BCL7a, PTPRG, and p73. J. Clin. Oncol. 23 (2005) 3886-3896
33. Mori T., Li Y., Hata H., Ono K., and Kochi H. NIRF, a novel RING finger protein, is involved in cell-cycle regulation. Biochem. Biophys. Res. Commun. 296 (2002) 530-536
34. Pasqualini J.R. The selective estrogen enzyme modulators in breast cancer: a review. Biochim. Biophys. Acta 1654 (2004) 123-143
35. Takai D., and Jones P.A. The CpG island searcher: a new WWW resource. In Silico Biol. 3 (2003) 235-240
36. Takai D., and Jones P.A. Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc. Natl. Acad. Sci. USA 99 (2002) 3740-3745
37. Savelyeva L., Claas A., Matzner I., Schlag P., Hoffman W., Scherneck S., Weber B., and Schwab M. Constitutional genomic instability with inversions, duplications, and amplifications in 9p23-24 in BRCA2 mutation carriers. Cancer Res. 61 (2001) 5179-5185
38. Gaudet F., Hogson J.G., Eden A., Jackson-Grusby L., Dausman J., Gray J.W., Leonhardt H., and Jaenisch R. Induction of tumors in mice by genomic hypomethylation. Science 300 (2003) 489-492
39. Yamada Y., Jackson-Grusby L., Linhart H., Meissner A., Eden A., Lin H., and Jaenisch R. Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis. Proc. Natl. Acad. Sci. USA 102 (2005) 13580-13585
40. Kaneda A., Tsukamoto T., Takamura-Enya T., Watanabe N., Kaminishi M., Sugimura T., Tatematsu M., and Ushijima T. Frequent hypomethylation in multiple promoter CpG islands is associated with global hypomethylation, but not with frequent promoter hypermethylation. Cancer Sci. 95 (2004) 58-64